第一单位：
Program of Hepatology, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
作者：
Alex,Claveria-Cabello [1]
;
Leticia,Colyn [1]
;
Iker,Uriarte [2]
;
Maria Ujue,Latasa [1]
;
Maria,Arechederra [3]
;
Jose M,Herranz [2]
;
Laura,Alvarez [1]
;
Jesus M,Urman [4]
;
Maria L,Martinez-Chantar [5]
;
Jesus M,Banales [6]
;
Bruno,Sangro [7]
;
Krista,Rombouts [8]
;
Julen,Oyarzabal [9]
;
Jose J G,Marin [10]
;
Carmen,Berasain [11]
;
Matias A,Avila [11]
;
Maite G,Fernandez-Barrena [11]
作者单位：
Program of Hepatology, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
[1]
Program of Hepatology, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.;National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), 28029 Madrid, Spain.
[2]
Program of Hepatology, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.;IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
[3]
IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.;Department of Gastroenterology and Hepatology, Navarra University Hospital Complex, 31008 Pamplona, Spain.
[4]
National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), 28029 Madrid, Spain.;Liver Disease Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, 48160 Derio, Spain.
[5]
National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), 28029 Madrid, Spain.;Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, 20014 San Sebastian, Spain.;IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain.
[6]
National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), 28029 Madrid, Spain.;IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.;Hepatology Unit, Department of Internal Medicine, University of Navarra Clinic, 31008 Pamplona, Spain.
[7]
Institute for Liver and Digestive Health, University College London, London NW3 2PF, UK.
[8]
Program of Molecular Therapeutics, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
[9]
National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), 28029 Madrid, Spain.;Experimental Hepatology and Drug Targeting (HEVEPHARM), University of Salamanca, Biomedical Research Institute of Salamanca (IBSAL), 37007 Salamanca, Spain.
[10]
Program of Hepatology, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.;National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), 28029 Madrid, Spain.;IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
[11]
DOI
10.3390/cancers12123748
PMID
33322158
发布时间
2020-12-29
换一批
